Eyeing RNAi potential in cancer and fibrosis, trans-Pacific biotech Sirnaomics lines up $47M Series C
With support from a syndicate that speaks to its extensive China ties, Gaithersburg, MD-based Sirnaomics has raised an additional $22 million to close out its …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.